Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe COVID-19”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT04619719
What this trial is testing

Hyperbaric Oxygen for COVID-19 Patients With Moderate to Severe Hypoxemia

Who this might be right for
Covid19
Legacy Health System 27
Not applicableStudy completedNCT04412551
What this trial is testing

Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19

Who this might be right for
Corona Virus InfectionVirus DiseasesCoronaviridae Infections
Dalarna County Council, Sweden 72
Testing effectiveness (Phase 2)UnknownNCT04977960
What this trial is testing

Efficacy of Canrenone as add-on Treatment in Moderate to Severe ARDS in COVID-19

Who this might be right for
COVID-19 Acute Respiratory Distress Syndrome
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 180
Testing effectiveness (Phase 2)Ended earlyNCT04679350
What this trial is testing

Efficacy and Safety of hzVSFv13 in Patients With COVID-19 Pneumonia

Who this might be right for
COVID-19
ImmuneMed, Inc. 1
Not applicableStudy completedNCT04389944
What this trial is testing

Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19

Who this might be right for
Coronavirus Disease 2019 Infectious Disease (COVID-19 Infection)
University Hospital, Basel, Switzerland 15
Not applicableStudy completedNCT04325906
What this trial is testing

Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS

Who this might be right for
Prone PositioningHigh Flow Nasal CannulaAcute Respiratory Distress Syndrome+1 more
Rush University Medical Center 224
Testing effectiveness (Phase 2)UnknownNCT04902183
What this trial is testing

Safety and Efficacy of Exosomes Overexpressing CD24 in Two Doses for Patients With Moderate or Severe COVID-19

Who this might be right for
Covid19
Athens Medical Society 90
Testing effectiveness (Phase 2)Study completedNCT04932941
What this trial is testing

MP1032 Treatment in Patients With Moderate to Severe COVID-19

Who this might be right for
COVID-19
MetrioPharm AG 132
Large-scale testing (Phase 3)Ended earlyNCT04421508
What this trial is testing

Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19

Who this might be right for
COVID-19CoronavirusCoronavirus Infection
Bellerophon Pulse Technologies 191
Not applicableStudy completedNCT04362059
What this trial is testing

A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19

Who this might be right for
Respiratory Infections
University Hospital Southampton NHS Foundation Trust 20
Early research (Phase 1)UnknownNCT04747574
What this trial is testing

Evaluation of the Safety of CD24-Exosomes in Patients With COVID-19 Infection

Who this might be right for
SARS-CoV-2
Tel-Aviv Sourasky Medical Center 35
Early research (Phase 1)Temporarily pausedNCT05387278
What this trial is testing

Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19)

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeRespiratory Distress Syndrome
Vitti Labs, LLC 20
Large-scale testing (Phase 3)Ended earlyNCT04695704
What this trial is testing

Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19:

Who this might be right for
Covid19SARS (Disease)
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 86
Large-scale testing (Phase 3)Study completedNCT04494984
What this trial is testing

Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.

Who this might be right for
COVID-19
Inmunova S.A. 243
Not applicableStudy completedNCT04667936
What this trial is testing

Evaluation of Sedation in COVID-19 ARDS

Who this might be right for
Prone PositionSevere Acute Respiratory Syndrome Coronavirus 2Hypnotics and Sedatives+1 more
Goethe University 114
Not applicableStudy completedNCT06767241
What this trial is testing

Transcranial Non-invasive Electrical Stimulation of the Vagus Nerve in Hospitalized Moderate-to-severe COVID-19 Patients

Who this might be right for
COVID-19
University of Medicine and Pharmacy "Victor Babes" Timisoara 83
Testing effectiveness (Phase 2)Ended earlyNCT05156671
What this trial is testing

Adrecizumab (HAM8101) to Improve Prognosis and Outcomes in COVID-19 Trial

Who this might be right for
COVID-19
Universitätsklinikum Hamburg-Eppendorf 16
Large-scale testing (Phase 3)Ended earlyNCT04492358
What this trial is testing

Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center

Who this might be right for
Covid19
Maria Joyera Rodríguez 54
Very early researchStudy completedNCT04412486
What this trial is testing

COVID-19 Convalescent Plasma (CCP) Transfusion

Who this might be right for
COVID-19
Gailen D. Marshall Jr., MD PhD 86
Large-scale testing (Phase 3)UnknownNCT04610541
What this trial is testing

REMdesivir-HU Clinical Study and Severe Covid-19 Patients

Who this might be right for
SARS-CoV-2 Infection
University of Pecs 2,000
Next Page